Last edition
News about
Racura Oncology Advances RC220 to Higher Dose Level in Phase 1 CPACS Cancer Trial
Racura Oncology has received approval from the Safety Review Committee to escalate the dose of investigational cancer therapy RC220 in its phase 1 CPACS clinical trial following positive safety findings in advanced metastatic cancer patients.
Chugai Secures World's First Tumour-Agnostic Approval for ALK Inhibitor Alecensa in Japan
Chugai Pharmaceutical has received regulatory approval in Japan for the expanded use of Alecensa (alectinib) in advanced or recurrent ALK fusion-positive solid tumours, marking the world’s first tumour-agnostic approval for an ALK inhibitor.
Merck's Phase 3 TroFuse-005 Trial Shows Survival Benefit of Sac-TMT in Advanced Endometrial Cancer
Merck announced that its phase 3 TroFuse-005 trial evaluating investigational antibody-drug conjugate Sacituzumab Tirumotecan (sac-TMT) met primary endpoints of overall survival and progression-free survival in patients with advanced or recurrent endometrial cancer.
Lundbeck Secures Orphan Drug Designation in Japan for Asedebart Targeting Rare Endocrine Disorders
Lundbeck has received orphan drug designation in Japan for asedebart, an investigational ACTH-targeting therapy being developed for congenital adrenal hyperplasia and Cushing’s disease.
Annora Pharma Expands Partnership with AltiusHub for Global Drug Traceability
Annora Pharma expands its collaboration with AltiusHub to enhance global drug traceability, improve serialisation efficiency, and strengthen multi-market regulatory compliance across export operations.
NIH-Backed Researchers Launch Open-Access Tool to Improve Amblyopia Care in Children
Researchers supported by the National Institutes of Health have introduced the Amblyopia Navigator Decision-Support Instrument (ANDI), an open-access tool designed to support evidence-based treatment of amblyopia in children.
Tamil Nadu Chemists Announces Statewide Shutdown on May 20 Over E-Pharmacy Concerns
Tamil Nadu Chemists and Druggists Association has announced a statewide shutdown of retail pharmacy outlets on May 20 following a directive from All India Organisation of Chemists and Druggists, citing concerns over unregulated e-pharmacy operations and online medicine sales.
RFiD Discovery Deploys RFID Inventory Tracking System for Sanofi R&D Sites
RFiD Discovery has implemented a passive RFID inventory management system for Sanofi, enabling real-time tracking of critical research materials at its R&D facilities in France and the United States.
Harbour BioMed Reports Promising Preclinical Data for AI-Driven Drug Candidate LET003
Harbour BioMed announced promising preclinical data for LET003, its first Artificial Intelligence (AI)-enabled drug candidate, highlighting potential as a next-generation obesity therapy targeting ACVR2A/2B.
UK MHRA Approves Vyjuvek for Treatment of Dystrophic Epidermolysis Bullosa Wounds
Medicines and Healthcare products Regulatory Agency has approved Vyjuvek for treating wounds in patients with dystrophic epidermolysis bullosa, including newborns.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy